188 related articles for article (PubMed ID: 37121974)
1. DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer.
Im JY; Kang MJ; Kim BK; Won M
Exp Mol Med; 2023 May; 55(5):879-885. PubMed ID: 37121974
[TBL] [Abstract][Full Text] [Related]
2. DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells.
Im JY; Kim BK; Lee JY; Park SH; Ban HS; Jung KE; Won M
Oncogene; 2018 Mar; 37(9):1251-1262. PubMed ID: 29242605
[TBL] [Abstract][Full Text] [Related]
3. DNA damage-induced apoptosis suppressor (DDIAS), a novel target of NFATc1, is associated with cisplatin resistance in lung cancer.
Im JY; Lee KW; Won KJ; Kim BK; Ban HS; Yoon SH; Lee YJ; Kim YJ; Song KB; Won M
Biochim Biophys Acta; 2016 Jan; 1863(1):40-9. PubMed ID: 26493727
[TBL] [Abstract][Full Text] [Related]
4. Stability of the cancer target DDIAS is regulated by the CHIP/HSP70 pathway in lung cancer cells.
Won KJ; Im JY; Kim BK; Ban HS; Jung YJ; Jung KE; Won M
Cell Death Dis; 2017 Jan; 8(1):e2554. PubMed ID: 28079882
[TBL] [Abstract][Full Text] [Related]
5. NFATc1 regulates the transcription of DNA damage-induced apoptosis suppressor.
Im JY; Lee KW; Won KJ; Kim BK; Ban HS; Yoon SH; Lee YJ; Kim YJ; Song KB; Won M
Data Brief; 2015 Dec; 5():975-80. PubMed ID: 26740967
[TBL] [Abstract][Full Text] [Related]
6. DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathway.
Im JY; Kim BK; Yoon SH; Cho BC; Baek YM; Kang MJ; Kim N; Gong YD; Won M
Exp Mol Med; 2021 Apr; 53(4):643-653. PubMed ID: 33859351
[TBL] [Abstract][Full Text] [Related]
7. DNA damage induced apoptosis suppressor (DDIAS) is upregulated via ERK5/MEF2B signaling and promotes β-catenin-mediated invasion.
Im JY; Yoon SH; Kim BK; Ban HS; Won KJ; Chung KS; Jung KE; Won M
Biochim Biophys Acta; 2016 Nov; 1859(11):1449-1458. PubMed ID: 27412911
[TBL] [Abstract][Full Text] [Related]
8. Miconazole inhibits signal transducer and activator of transcription 3 signaling by preventing its interaction with DNA damage-induced apoptosis suppressor.
Yoon SH; Kim BK; Kang MJ; Im JY; Won M
Cancer Sci; 2020 Jul; 111(7):2499-2507. PubMed ID: 32476221
[TBL] [Abstract][Full Text] [Related]
9. DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells.
Im JY; Kim BK; Lee KW; Chun SY; Kang MJ; Won M
Oncogenesis; 2020 Jan; 9(1):1. PubMed ID: 31900385
[TBL] [Abstract][Full Text] [Related]
10. Data on the transcriptional regulation of DNA damage induced apoptosis suppressor (DDIAS) by ERK5/MEF2B pathway in lung cancer cells.
Im JY; Yoon SH; Kim BK; Ban HS; Won KJ; Chung KS; Jung KE; Won M
Data Brief; 2016 Dec; 9():257-61. PubMed ID: 27660814
[TBL] [Abstract][Full Text] [Related]
11. DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma?
Pascale RM; Joseph C; Latte G; Evert M; Feo F; Calvisi DF
DNA Repair (Amst); 2016 Nov; 47():12-20. PubMed ID: 27789167
[TBL] [Abstract][Full Text] [Related]
12. DNA Damage-Induced Apoptosis Suppressor Triggers Progression and Stemness of Glioma by Enhancing Lymphoid Enhancer-Binding Factor 1 Expression.
Chen YL; Liu Y; Xu Y; Yang AQ; Chen GJ; Xing JS; Su HW; Liao LS
World J Oncol; 2024 Apr; 15(2):209-222. PubMed ID: 38545470
[TBL] [Abstract][Full Text] [Related]
13. DDIAS promotes invasion and proliferation of non-small cell lung cancer and predicts poor survival of lung cancer patients.
Liu N; Zhang X; Zhou H; Cai L; Li A; Miao Y; Li Q; Qiu X; Wang E
Int J Clin Exp Pathol; 2017; 10(12):11506-11515. PubMed ID: 31966506
[TBL] [Abstract][Full Text] [Related]
14. Potent effects of dioscin against hepatocellular carcinoma through regulating TP53-induced glycolysis and apoptosis regulator (TIGAR)-mediated apoptosis, autophagy, and DNA damage.
Mao Z; Han X; Chen D; Xu Y; Xu L; Yin L; Sun H; Qi Y; Fang L; Liu K; Peng J
Br J Pharmacol; 2019 Apr; 176(7):919-937. PubMed ID: 30710454
[TBL] [Abstract][Full Text] [Related]
15. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
[TBL] [Abstract][Full Text] [Related]
16. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
[TBL] [Abstract][Full Text] [Related]
17. ATM kinase activity modulates cFLIP protein levels: potential interplay between DNA damage signalling and TRAIL-induced apoptosis.
Stagni V; Mingardi M; Santini S; Giaccari D; Barilà D
Carcinogenesis; 2010 Nov; 31(11):1956-63. PubMed ID: 20876284
[TBL] [Abstract][Full Text] [Related]
18. Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma.
Yu L; Huang X; Zhang W; Zhao H; Wu G; Lv F; Shi L; Teng Y
Oncotarget; 2016 May; 7(18):26844-55. PubMed ID: 27057626
[TBL] [Abstract][Full Text] [Related]
19. The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma.
Lu S; Zhou J; Sun Y; Li N; Miao M; Jiao B; Chen H
Mol Cancer; 2017 Jul; 16(1):125. PubMed ID: 28724429
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
